ISMRM Workshop on

Frontiers in Metabolomics & Metabolomic Imaging in Medicine:

Challenges & Opportunities

Endorsed by the Metabolomics Society & World Molecular Imaging Society (WMIS).

calendar_month

16-18 October 2025

location_on

Cultural Center Altinate San Gaetano
Padua, Italy

Co-Chairs

Leo L. Cheng, Ph.D.

Candace C. Fleischer, Ph.D.

Register Now

Early Registration Deadline:

Declarations & Supporters

Faculty declarations will be available approximately two weeks before the workshop begins.

Registration & Travel

Register Now

Early Registration & Cancellation Deadline:
16 September 2025 at 23:59 UTC

Travel & Housing Information

Need an Invitation Letter?
Please download and complete this self-fillable PDF letter.

For Presenters & Attendees

Program Options:
Scroll Down | Open Separately

Guidelines for Presenters & Posters

Attendee Code of Conduct

Sustainability

ISMRM Sustainability Initiatives

Get the Flyer. Tell Your Colleagues.

Download & share this flyer to help us promote this valuable ISMRM workshop.

Overview & Program

Workshop Overview

Disease and medical conditions can variably affect overall physiological and metabolic homeostasis. Metabolomics, which provides a wholistic and comprehensive quantification of metabolic alterations from tissues or biofluids, has the potential to revolutionize disease diagnosis, patient prognostication, and personalized/precision medicine. Currently, medical metabolomics are predominantly evaluated by NMR and mass spectrometry, and complemented by methodologies such as PET, hyperpolarized NMR, MRS, etc. This workshop is designed to bring together metabolomic researchers spanning academia, healthcare, and industry, each with unique methodological perspectives, to promote free discourse and exploration of metabolomics. Our aim is to establish a unifying platform on which medical metabolomics, through biospecimen evaluation and in vivo imaging, can be translated into clinical implementations.

The workshop will cover the following topics: 1) the fundamentals of NMR- and MS-based metabolomics; 2) additional imaging technologies that provide localized metabolomic measures; 3) current challenges in disease diagnosis and detection, and opportunities for medical metabolomics to advance these fields; 4) big data approaches to metabolomics in the era of artificial intelligence and machine learning; and 5) perspectives from funding agencies and research institutes on progressing medical metabolomics forward. Invited speakers will include members from the ISMRM and non-member experts both within and outside the realm of MR technologies. By facilitating dialogue and collaboration, our goal is to establish a medical metabolomics network dedicated to achieving common goals.

Target Audience

This inaugural Metabolomics and Metabolomic Imaging (MMI) workshop is designed for scientists, clinicians, and trainees from academia, healthcare, and industry, who seek to learn and discuss the frontiers of metabolomics in medicine. The central foci of this workshop are medical metabolomics and metabolomic imaging, a burgeoning field with enormous potential for medical applications. These malignant and neurodegenerative diseases present wholistic metabolic alterations that can only be collectively evaluated by metabolomics. At present, metabolomics studies are predominantly conducted by NMR and mass spectrometry, and complemented by methodologies such as PET, hyperpolarized NMR, MRS, and others. By uniting leaders from various methodological domains of metabolomics, along with pioneers in data science, artificial intelligence, and machine learning, we aim to create an environment conducive to open discussion and collaboration. Our goal is to propel the development of medical metabolomics and metabolomic imaging for clinical implementation.

Educational Objectives

Upon completion of this activity, participants should be able to:

Preliminary Program

Day 1 - Thursday, 16 October 2025

8:00

Registration & Speaker Upload Available

Session 1: NMR Metabolomics & Imaging

Moderators: T.B.A.

9:00

Welcome

Leo Cheng, Ph.D. &
Candace Fleischer, Ph.D.

9:15

Overview: NMR Metabolomics & Imaging

Joseph J. H. Ackerman, Ph.D.
Washington University in St. Louis
St. Louis, MO, USA

9:30

Keynote: NMR Metabolomics & Imaging

Zaver M. Bhujwalla, Ph.D.
Johns Hopkins University School of Medicine
Baltimore, MD, USA

10:15

2D MRS Breast

Carolyn Mountford, D.Phil.
DatChem
Brisbane, QLD, Australia

10:40

Break & Speaker Upload Available

11:10

MRSI & Metabolomic Imaging

Jie Luo, Ph.D.
Shanghai Jiao Tong University
Shanghai, China

11:35

CEST & Metabolomics

T.B.A.

12:00

Proffered Papers - Oral Session

12:30

Lunch & Speaker Upload Available

14:00

Vendor Session

Session 2: Clinical Needs

Moderators: T.B.A.

15:00

Overview: Clinical Needs

Victor Ferrari, M.D.
Hospital of University of Pennsylvania
Philadelphia, PA, USA

15:15

Keynote: Clinical Needs

Richard L. Ehman, M.D.
Mayo Clinic
Rochester, MN, USA

16:00

Break & Speaker Upload Available

16:30

Pathology

T.B.A.

16:55

Cardiology

T.B.A.

17:20

Oncologist

T.B.A.

17:45

Proffered Papers - Oral Session

18:30

Adjourn

19:00

Networking Reception

Day 2 - Friday, 17 October 2025

8:00

Registration & Speaker Upload Available

Session 3: MS Based Metabolomics & Imaging

Moderators: T.B.A.

9:00

MS Metabolomics & Imaging

T.B.A.

9:15

Keynote: MS Metabolomics & Imaging

David Wishart, Ph.D.
University of Alberta
Edmonton, AB, Canada

10:00

MS Based Metabolomics & Imaging

T.B.A.

10:25

Break & Speaker Upload Available

10:55

MS & Metabolomic Imaging

Julia Kuligowski, Ph.D.
Health Research Institute La Fe
Valencia, Spain

11:20

MS Methods

Andrea Armirotti, Ph.D.
Istituto Italiano di Tecnologia
Genova, Italy

11:45

Proffered Papers - Oral Session

12:30

Lunch & Speaker Upload Available

14:00

Poster Session

Session 4: Multi-Modality & Imaging

Moderators: T.B.A.

15:00

Overview: Multi-Modality & Imaging

Charles S. Springer, Jr., Ph.D.
Oregon Health & Science University
Portland, OR, USA

15:15

Keynote: Multi-Modality Imaging

Stephen Barnes, Ph.D.
University of Alabama at Birmingham
Birmingham, AL, USA

16:00

PET

H. Charles Manning, Ph.D.
MD Anderson Cancer Center
Houston, TX, USA

16:25

Multi-Nuclear Imaging

T.B.A.

16:50

Break & Speaker Upload Available

17:20

Raman Spectroscopy

T.B.A.

17:45

HP

Kayvan Rahimi-Keshari, Ph.D.
Memorial Sloan-Kettering Cancer Center
New York, NY, USA

18:10

dwMRS

Itamar Ronen, Ph.D.
Brighton & Sussex Medical School
Sussex, England, UK

18:35

Adjourn

19:00

Networking Dinner

Day 3 - Saturday, 18 October 2025

8:30

Registration & Speaker Upload Available

Session 5: AI & ML Multi-omics

Moderators: T.B.A.

9:00

Overview: AI, ML Multi-omics

T.B.A.

9:15

Keynote: AI, ML Multi-omics

Hui Mao, Ph.D.
Emory University School of Medicine
Atlanta, GA, USA

10:00

Genomics Reporters

Xiaoping Philip Hu, Ph.D.
University of California, Riverside
Riverside, CA, USA

10:25

Break & Speaker Upload Available

10:55

Omics

T.B.A.

11:20

AI & ML

T.B.A.

11:45

Proffered Papers - Oral Session

12:30

Lunch & Speaker Upload Available

14:00

Poster Session

Session 6: Future of MMI

Moderators: T.B.A.

15:00

Overview: Future of MMI

T.B.A.

15:15

NCI

T.B.A.

15:40

Technology Evaluation

T.B.A.

16:05

Panel Discussion

T.B.A.

16:30

Break & Speaker Upload Available

17:00

MRs & MS Metabolomic Imaging

T.B.A.

17:25

Keynote: Future of MMI

Daniel Raftery, Ph.D.
University of Washington
Seattle, WA, USA

18:10

Closing Remarks

Leo Cheng, Ph.D. &
Candace Fleischer, Ph.D.

18:30

Adjourn

19:30

Networking Dinner